Vivek Subbiah: Transforming the fragmented silos of medicine into a wheel of collaboration
Vivek Subbiah, Chief, Early-Phase Drug Development at Sarah Cannon Research Institute, shared a post by
” Delighted to share the Nature Medicine World View on – “Fragmentation in medicine harms patients and hinders research“. Yes! Transforming the fragmented silos of medicine into a wheel of collaboration holds the key to tackling complex health challenges for generations to come. A big thank you to Ben Johnson at Nature Medicine for the vision and effort to get this important piece published.
United, together and breaking open the SILOS of MEDICINE we have the power to create a healthcare system that is both more cohesive and efficient.”
Quoting
“Medicine is increasingly fragmented, with siloed practices operating in isolation.Cross-disciplinary collaboration between medical specialties would improve patient care and foster clinical research, argues Vivek Subbiah in a World View for Nature Medicine, Nature Portfolio.”
Title: Fragmentation in medicine harms patients and hinders research
Author: Vivek Subbiah
Source: Vivek Subbiah/LinkedIn
Vivek Subbiah is the Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA). He is the former Executive Director of Oncology Research and former Associate Professor in the Department of Investigational Cancer Therapeutics at the MD Anderson Cancer.
He focuses on translational cancer research and the design and implementation of early-phase biomarker-driven clinical trials. His work specifically targets antibody-drug conjugates, radiopharmaceuticals, immunoconjugates, and basket trials.